Patients suffering from seizures often turn to the medication Dilantin (Phenytoin). Unfortunately, research suggests that Dilantin can lead to further troubles, including a cerebral atrophy prognosis.

Cerebral atrophy, or shrinkage of the brain, may occur as the result of the anticonvulsant drug Dilantin accumulating in the cerebral cortex area of the brain.

One of the studies looking at this link detailed the case of a 65 year old female patient who allegedly received a cerebral atrophy prognosis after taking Dilantin for a long period of time.

According to the study, the patient’s cerebral atrophy symptoms included trouble walking, going up and down stairs, and performing daily household chores. Even after her dosage of Dilantin was reduced, the woman did not fully regain her sense of balance.

The correlation between Dilantin and cerebral atrophy has been suspected since 1994. In one early study, scientists noted phenytoin patients had significantly smaller cerebeli compared to non-phenytoin patients.

Overview of Cerebral Atrophy Prognosis

Cerebral atrophy occurs when brain tissue deteriorates and loses neurological connections between the different areas of the organ.

This condition can either be focal, or affect the entire brain. The condition has the potential to permanently impair basic movements. Due to its severity, medical diagnosis and early intervention are vital for recovery.

Cerebral atrophy treatment depends on the severity of the case, and what stage the condition is at during diagnosis. Case reports have shown that long term exposure to Dilantin increases the chances of severe cerebral atrophy prognosis, while other studies show that medically supervised withdrawal stopped the progression of the condition in some patients.

Cerebral atrophy symptoms include degrading coordination, walking, and talking. Dilantin patients should see their doctors when they experience:

• Impaired coordination in the trunk or arms and legs
• Unsteady Walking
• Uncontrolled or repetitive eye movements
• Slurred Speech
• Headaches
• Dizziness

Depending on the cause of the condition, a cerebral atrophy prognosis can evolve slowly or quickly.

While there is no cure for the condition, the damage can be controlled with cerebral atrophy treatment.

Patients who have suffered from cerebral atrophy after taking Dilantin may be eligible for a product liability lawsuit. Potential claimants should contact a specialized lawyer to determine if they have a Dilantin cerebral atrophy claim.